Influenza antiviral treatment declined significantly among hospitalized children after COVID-19, highlighting gaps in guideline-recommended care.
Natasha Halasa, MD, MPH
Advertisement
Natasha Halasa, MD, MPH, is a professor of pediatric infectious diseases at Vanderbilt University Medical Center.
Articles by Natasha Halasa, MD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Recent advances in the treatment of molluscum contagiosum
2
FDA approves first generic rifapentine for tuberculosis treatment, prevention in 12 years and older
3
FDA grants priority review to Tivicay PD for neonatal HIV
4
Endocrine-disrupting chemicals detected in breast milk and infant urine through 6 months of age
5